Case Study: Medable Beats Forecasted FPI Date While Raising eCOA Adherence In Japan

A leading global pharmaceutical company faced significant challenges in Japan due to the region’s unique regulatory, cultural, and logistical landscape. Partnering with Medable allowed the company to address its challenges with patient enrollment and electronic Clinical Outcome Assessment (eCOA) adherence. The partnership allowed them to implement a tailored, region-specific strategy to streamline clinical trial operations and improve patient and site experiences.

Medable’s approach included direct engagement with Japanese study teams, ensuring localized support through weekly meetings and customized training. To enhance accessibility and adherence, all patient and site materials—including apps and onboarding resources—were fully translated into Japanese before the First Patient In (FPI) date. Additionally, Medable procured and tested compliant devices locally, mitigating potential regulatory delays. This initiative resulted in a seamless execution, with full site and Clinical Research Associate (CRA) training completed before FPI. Find out how, by addressing key operational barriers, Medable delivered a transformative solution that enhanced trial efficiency and patient compliance in a highly regulated market.